In the 6–24 hour window, thrombectomy is indicated based on which criteria?

Get ready for the Hemisphere IV Rapid Stroke Response Test. Study with flashcards and multiple choice questions, each question has hints and explanations. Prepare effectively and boost your confidence for the exam!

Multiple Choice

In the 6–24 hour window, thrombectomy is indicated based on which criteria?

Explanation:
In the 6–24 hour window, deciding on thrombectomy relies on tissue viability rather than time alone. The essential idea is to find a region of brain that is already damaged (the core) but has a surrounding area that is still at risk but salvageable (the penumbra). If there’s a favorable mismatch showing substantial salvageable tissue, reperfusion can still yield meaningful benefit. Trials like DAWN and DEFUSE-3 formalized this approach. They demonstrated that patients with a meaningful clinical-imaging mismatch or perfusion mismatch—where the core is small enough and there is a sizable penumbra—can benefit from thrombectomy up to 24 hours after onset. In practice, this means using perfusion imaging (CT or MR) to estimate the infarct core and the at-risk tissue, or applying the DAWN criteria that combine clinical factors with imaging to identify patients who still have salvageable tissue. So, the best way to decide in this extended window is to look for that mismatch and proceed if the imaging and clinical profile indicate salvageable tissue, rather than relying on time alone. Large infarct cores or absence of a mismatch would argue against thrombectomy, whereas a favorable mismatch supports proceeding, even if IV tPA has already been given or is contraindicated.

In the 6–24 hour window, deciding on thrombectomy relies on tissue viability rather than time alone. The essential idea is to find a region of brain that is already damaged (the core) but has a surrounding area that is still at risk but salvageable (the penumbra). If there’s a favorable mismatch showing substantial salvageable tissue, reperfusion can still yield meaningful benefit.

Trials like DAWN and DEFUSE-3 formalized this approach. They demonstrated that patients with a meaningful clinical-imaging mismatch or perfusion mismatch—where the core is small enough and there is a sizable penumbra—can benefit from thrombectomy up to 24 hours after onset. In practice, this means using perfusion imaging (CT or MR) to estimate the infarct core and the at-risk tissue, or applying the DAWN criteria that combine clinical factors with imaging to identify patients who still have salvageable tissue.

So, the best way to decide in this extended window is to look for that mismatch and proceed if the imaging and clinical profile indicate salvageable tissue, rather than relying on time alone. Large infarct cores or absence of a mismatch would argue against thrombectomy, whereas a favorable mismatch supports proceeding, even if IV tPA has already been given or is contraindicated.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy